Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPI-Rebound-Trial: Clinical Relevance of Acid Rebound
NCT00526006Phase 4Unknown
- Sponsor
- Zealand University Hospital
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esomeprazole in gastroesophageal reflux disease (GERD), sponsored by Zealand University Hospital. Status: unknown.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00526006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00526006.